Human dendritic cell vaccine sensitized with HER2/neu mRNA (Shanghai Haixin Bio-Tech)
HER2/neu mRNA 致敏的人树突状细胞疫苗（上海海欣生物技术）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameHuman dendritic cell vaccine sensitized with HER2/neu mRNA (Shanghai Haixin Bio-Tech)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (IND)
Highest Status in ChinaDiscontinued
Originator CompaniesShanghai Haixin Bio-Tech Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesShanghai Haixin Bio-Tech Co Ltd
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A